DMDWarrior Clinical Trials Search Tool helps families find Duchenne muscular dystrophy clinical trials worldwide by filtering studies by age, mutation type, treatment approach, recruitment status, and country.
The DMDWarrior Clinical Trials Search Tool is a free online resource that helps families search and compare Duchenne muscular dystrophy (DMD) clinical trials worldwide. Users can filter studies by age, recruitment status, therapeutic approach, exon mutation, country, and other eligibility criteria to quickly find relevant clinical trials. The platform provides up-to-date information on gene therapy, exon skipping, gene editing, and other investigational DMD treatments.

DMD Clinical Trial Statistics

Visual overview of Duchenne muscular dystrophy clinical trials in this catalog — by country, sponsor country, status, therapeutic approach and phase.

47

Total trials

33

Recruiting trials

28

Countries represented

About These DMD Clinical Trial Statistics

These charts summarize the Duchenne clinical trials maintained in the DMD Warrior catalog. They are intended for advocacy, research awareness, and high-level comparison — for example, how many trials run in a given country, which phases dominate, or how research splits across therapeutic approaches.

The country chart counts trials with at least one study site in each location; a single trial may appear in more than one country. The sponsor country chart reflects where the trial sponsor is headquartered, as entered in the admin catalog, and highlights which nations are leading treatment development for Duchenne.

Status and phase charts show how studies are distributed across recruitment states and clinical phases. The therapeutic approach chart groups trials into standardized categories such as gene therapy and exon skipping so trends are easier to read than raw study titles alone.

All figures are derived from the same trial records shown in Trial Search and Active DMD Clinical Studies. The catalog was last updated August 11, 2026; counts change when new trials are added or existing records are revised in the admin panel.

Clinical trials by country

Number of trials with at least one site in each country. Trials spanning multiple countries are counted once per country.

  • United States31
  • United Kingdom13
  • Spain12
  • Italy11
  • Belgium9
  • Canada8
  • Australia6
  • China5
  • Japan4
  • South Korea4
  • Netherlands4
  • Turkiye4
  • Germany3
  • Poland3
  • France2
  • Hong Kong2
  • Jordan2
  • Taiwan2
  • Belarus1
  • Denmark1
  • Ireland1
  • Israel1
  • New Zealand1
  • Puerto Rico1
  • Serbia1
  • Russia1
  • Sweden1
  • Ukraine1

A single trial may appear under more than one country if it runs in multiple locations.

Countries Leading DMD Treatment Development

Leadership is earned, not claimed. It's time for more countries to prove they can change the future of Duchenne.

  • United States34
  • China5
  • Canada2
  • Switzerland2
  • Japan2
  • France1
  • Russia1

By study status

Current recruitment and completion status across all catalogued trials.

  • Actively Recruiting23
  • Active, Not Recruiting14
  • Enrolling by Invitation5
  • Not Yet Recruiting5

By clinical trial phase

Trial phase labels as listed in each study record.

  • Phase 215
  • Phase 1/210
  • Phase 36
  • Early Phase 15
  • Phase 14
  • Observational3
  • Phase 42
  • Interventional1
  • Phase 2/31

By therapeutic approach

Trials grouped by standardized therapeutic approach category.

  • Gene Therapy16
  • Exon Skipping15
  • Improving Muscle Growth & Protection8
  • Other Therapeutic Approaches2
  • Reducing Inflammation2
  • Enhancing Bone Health1
  • Gene Editing1
  • Improving Heart Function1
  • mRNA / tRNA / saRNA Therapies1